Alterations in White Matter Microstructure in Neurofibromatosis-1

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Karlsgodt, Katherine H ^a,b   Rosser, Tena ^c   Lutkenhoff, Evan S ^b   Cannon, Tyrone D ^a,b   Silva, Alcino ^a,b,d   Bearden, Carrie E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; AXIAL DIFFUSION; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMYELINATION; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GRAY MATTER; HUMAN; MALE; NERVE FIBER; NEUROFIBROMATOSIS; NEUROIMAGING; RADIAL DIFFUSION; THALAMUS ANTERIOR NUCLEUS; WHITE MATTER;

ADULT; ANISOTROPY; AXONS; CASE-CONTROL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MALE; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; ORGAN SIZE; THALAMUS;

EID: 84867673530     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047854     Document Type: Article

References (65)

1. Shilyansky C, Karlsgodt K, Cummings DM, Sidiropoulou K, Hardt M, et al. (2010) Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proceedings of the National Academy of Sciences 107: 13141-13146.
2. Huson SM, (1989) Recent developments in the diagnosis and management of neurofibromatosis. Arch Dis Child 64: 745-749.
3. Ozonoff S, (1999) Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 89: 45-52.
4. Rowbotham I, Pit-ten Cate IM, Sonuga-Barke EJ, Huijbregts SC, (2009) Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology 23: 50-60.
5. North K, Joy P, Yuille D, Cocks N, Mobbs E, et al. (1994) Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 44: 878-883.
6. North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, et al. (1997) Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48: 1121-1127.
7. Hyman SL, Shores A, North KN, (2005) The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65: 1037-1044.
8. Mautner VF, Kluwe L, Thakker SD, Leark RA, (2002) Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol 44: 164-170.
9. Huijbregts SC, de Sonneville LM, (2011) Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behav Genet 41: 430-436.
10. Gillberg C, Forsell C, (1984) Childhood psychosis and neurofibromatosis-more than a coincidence? J Autism Dev Disord 14: 1-8.
11. North K, (2000) Neurofibromatosis type 1. Am J Med Genet 97: 119-127.
12. Cutting LE, Cooper KL, Koth CW, Mostofsky SH, Kates WR, et al. (2002) Megalencephaly in NF1: predominantly white matter contribution and mitigation by ADHD. Neurology 59: 1388-1394.
13. Moore BD, 3rd, Slopis JM, Jackson EF, De Winter AE, Leeds NE (2000) Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 54: 914-920.
14. Greenwood RS, Tupler LA, Whitt JK, Buu A, Dombeck CB, et al. (2005) Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Arch Neurol 62: 1904-1908.
15. Payne JM, Moharir MD, Webster R, North KN, (2010) Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 81: 304-309.
16. Dubovsky EC, Booth TN, Vezina G, Samango-Sprouse CA, Palmer KM, et al. (2001) MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 22: 190-195.
17. Kayl AE, Moore BD, 3rd, Slopis JM, Jackson EF, Leeds NE (2000) Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 15: 90-96.
18. Margariti PN, Blekas K, Katzioti FG, Zikou AK, Tzoufi M, et al. (2007) Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1. Eur Radiol 17: 433-438.
19. Pride N, Payne JM, Webster R, Shores EA, Rae C, et al. (2010) Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1. J Child Neurol 25: 834-841.
20. Viskochil D, Cawthon R, O'Connell P, Xu GF, Stevens J, et al. (1991) The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol Cell Biol 11: 906-912.
21. Bennett A O MR, (2008) Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin. Aust NZ J Psychiatry 42: 662-677.
22. Lee JS, Padmanabhan A, Shin J, Zhu S, Guo F, et al. (2010) Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. Hum Mol Genet 19: 4643-4653.
23. Basser PJ, Jones DK, (2002) Diffusion-tensor MRI: Theory, experimental design and data analysis- A technical review. NMR in Biomedicine 15: 456-467.
24. Karlsgodt KH, Jacobson SC, Seal M, Fusar-Poli P, (2012) The relationship of developmental changes in white matter to the onset of psychosis. Curr Pharm Des 18: 422-433.
25. Eastwood JD, Fiorella DJ, MacFall JF, Delong DM, Provenzale JM, et al. (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 219: 354-358.
26. Tognini G, Ferrozzi F, Garlaschi G, Piazza P, Patti A, et al. (2005) Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1. J Comput Assist Tomogr 29: 298-304.
27. Alkan A, Sigirci A, Kutlu R, Ozcan H, Erdem G, et al. (2005) Neurofibromatosis type 1: diffusion weighted imaging findings of brain. Eur J Radiol 56: 229-234.
28. Wignall EL, Griffiths PD, Papadakis NG, Wilkinson ID, Wallis LI, et al. (2010) Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 31: 856-861.
29. Zamboni SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA, (2007) Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 28: 773-776.
30. van Engelen SJ, Krab LC, Moll HA, de Goede-Bolder A, Pluijm SM, et al. (2008) Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR Am J Neuroradiol 29: 816-822.
31. Wozniak JR, Lim KO, (2006) Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neuroscience and Biobehavioral Reviews 30: 762-774.
32. Song AW, Harshbarger T, Li T, Kim KH, Ugurbil K, et al. (2003) Functional activation using apparent diffusion coefficient-dependent contrast allows better spatial localization to the neuronal activity: Evidence using diffusion tensor imaging and fiber tracking. NeuroImage.
33. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, et al. (2005) Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140.
34. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ, (2010) Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 133: 529-539.
35. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, et al. (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436.
36. Ford JC, Hackney DB, Lavi E, Phillips M, Patel U, (1998) Dependence of apparent diffusion coefficients on axonal spacing, membrane permeability, and diffusion time in spinal cord white matter. J Magn Reson Imaging 8: 775-782.
37. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, et al. (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 104: 14501-14506.
38. Golabchi FN, Brooks DH, Hoge WS, De Girolami U, Maier SE, (2010) Pixel-based comparison of spinal cord MR diffusion anisotropy with axon packing parameters. Magn Reson Med 63: 1510-1519.
39. Conference NIoHCD (1988) Neurofibromatosis: Conference Statement. Archives of Neurology. 575-578.
40. First MB, Spitzer R, Gibbon M, Williams J (1997) Structured Clinical Interview for DSM-IV Axis I Disorders. New York: Biometrics Research Department, New York State Psychiatric Institute.
41. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1):: S208-219.
42. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. (2006) Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
43. Ashburner J, Friston KJ, (2000) Voxel-based morphometry-the methods. Neuroimage 11: 805-821.
44. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, et al. (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21-36.
45. Smith S, (2002) Fast robust automated brain extraction. Human Brain Mapping 17: 143-155.
46. Zhang Y, Brady M, Smith S, (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging 20: 45-57.
47. Jenkinson M, Smith S, (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
48. Jenkinson M, Bannister P, Brady M, Smith S, (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17: 825-841.
49. Andersson J, Jenkinson M, Smith S (2007) Non-linear optimisation. FMRIB Technical Report TR07JA1 www.fmrib.ox.ac.uk/analysis/techrep.
50. Andersson J, Jenkinson M, Smith S (2007) Non-linear registration, aka Spatial normalisation. FMRIB Technical Report TR07JA2 www.fmrib.ox.ac.uk/analysis/techrep.
51. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, et al. (1999) Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 18: 712-721.
52. Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PC (2005) MRI Atlas of Human White Matter. Amsterdam: Elsevier.
53. Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M, et al. (2007) Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 36: 630-644.
54. Hua K, Zhang J, Wakana S, Jiang H, Li X, et al. (2008) Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 39: 336-347.
55. Karlsgodt K, Niendam TA, Bearden CE, Cannon TD, (2009) White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry 66: 562-569.
56. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, et al. (1995) Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 195: 721-724.
57. Sheikh SF, Kubal WS, Anderson AW, Mutalik P, (2003) Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1. J Comput Assist Tomogr 27: 681-686.
58. Johnson MR, Ferner RE, Bobrow M, Hughes RA, (2000) Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 68: 643-646.
59. Mikol DD, Rongnoparut P, Allwardt BA, Marton LS, Stefansson K, (1993) The oligodendrocyte-myelin glycoprotein of mouse: primary structure and gene structure. Genomics 17: 604-610.
60. Gil V, Bichler Z, Lee JK, Seira O, Llorens F, et al. (2010) Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon. Cereb Cortex 20: 1769-1779.
61. Kweh F, Zheng M, Kurenova E, Wallace M, Golubovskaya V, et al. (2009) Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. Mol Carcinog 48: 1005-1017.
62. Boyanapalli M, Lahoud OB, Messiaen L, Kim B, Anderle de Sylor MS, et al. (2006) Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem Biophys Res Commun 340: 1200-1208.
63. Tamm L, Barnea-Goraly N, Reiss AL, (2012) Diffusion tensor imaging reveals white matter abnormalities in Attention-Deficit/Hyperactivity Disorder. Psychiatry Res 202: 150-154.
64. de Zeeuw P, Mandl RC, Hulshoff Pol HE, van Engeland H, Durston S, (2012) Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder. Hum Brain Mapp 33: 1941-1951.
65. Nagel BJ, Bathula D, Herting M, Schmitt C, Kroenke CD, et al. (2011) Altered white matter microstructure in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50: 283-292.